10:32 AM EST - MedReleaf Corp. : Announced financial and operating results for the year end fiscal 2018 ending March 31, 2018. Record sales of $43.6 million, an increase of 8%, compared to the prior fiscal year. Adjusted EBITDA loss of $2.3 million, compared to $13.9 million for the prior fiscal year due to increased overhead costs and investments in recreational brands, international business initiatives, and increased research and development efforts. MedReleaf Corp.
shares T.LEAF are trading up $0.64 at $27.30.
